ALMIRALL, S.A. «12345...» Página 2 de 48 desde 01/07/1988 hasta 12/09/2024 11/11/2019 07:47 ALMIRALL, S.A. Announcements of public presentations and meetings Q3 2019 Conference Call with analysts and Institutional investors Número de registro: 283469 11/11/2019 07:38 ALMIRALL, S.A. Interim financial information La sociedad remite información sobre los resultados del tercer trimestre de 2019 Número de registro: 283468 28/10/2019 07:57 ALMIRALL, S.A. R&D: new licenses, patents and registered trademarks ALMIRALL ANNOUNCES PIPELINE UPDATE Número de registro: 282907 21/10/2019 07:55 ALMIRALL, S.A. Strategic agreements with third parties Almirall: to receive $100 MM milestone from the agreement with AstraZeneca Número de registro: 282701 16/09/2019 07:50 ALMIRALL, S.A. Composition of other management and supervisory bodies ALMIRALL ANNOUNCES CFO LEADERSHIP TRANSITION Número de registro: 281740 29/07/2019 07:34 ALMIRALL, S.A. Announcements of public presentations and meetings Almirall announces that a webcast with analysts and institutional investors will be held today at 10.00 am CET related to the H1 2019 Financial Results. Número de registro: 280690 29/07/2019 07:28 ALMIRALL, S.A. Information on P&L First semester results presentation 2019 Número de registro: 280686 29/07/2019 07:22 ALMIRALL, S.A. Interim financial information La sociedad remite información sobre los resultados del primer semestre de 2019 Número de registro: 280685 22/07/2019 08:33 ALMIRALL, S.A. Liquidity contracts and specialists La Sociedad informa de las operaciones realizadas en el segundo trimestre de vigencia del contrato de liquidez Número de registro: 280398 Relacionado con 275658 del 04/03/2019 (18:23) 25/06/2019 15:56 ALMIRALL, S.A. R&D: new licenses, patents and registered trademarks Presentation webcast: License Agreement of lebrikizumab for Atopic Dermatitis in Europe Número de registro: 279545 Página 2 de 48 «12345...»